Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,672 | -3,285 | -8,727 | -13,101 | -6,163 |
| Depreciation Amortization | 517 | 270 | 486 | 249 | 509 |
| Accounts receivable | N/A | 2,319 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 2,657 | N/A | N/A | N/A |
| Other Working Capital | -2,268 | 5,576 | -2,058 | -654 | 6,622 |
| Other Operating Activity | 371 | -4,976 | 792 | 11,076 | 152 |
| Operating Cash Flow | $-5,052 | $2,561 | $-9,507 | $-2,430 | $1,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -261 | -97 | -244 | -68 | -44 |
| Purchase Sale Intangibles | N/A | -36 | N/A | N/A | N/A |
| Other Investing Activity | -81 | -36 | -117 | 0 | 0 |
| Investing Cash Flow | $-342 | $-133 | $-361 | $-68 | $-44 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,090 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 15,000 | N/A | N/A | N/A |
| Other Financing Activity | 9,726 | -691 | 33,954 | 6,068 | -1,391 |
| Financing Cash Flow | $9,726 | $16,398 | $33,954 | $6,068 | $-1,391 |
| Exchange Rate Effect | -238 | -1,052 | 126 | 6 | -112 |
| Beginning Cash Position | 29,498 | 29,498 | 5,285 | 5,285 | 5,711 |
| End Cash Position | 33,592 | 47,273 | 29,498 | 8,862 | 5,285 |
| Net Cash Flow | $4,094 | $17,775 | $24,212 | $3,576 | $-426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,052 | 2,561 | -9,507 | -2,430 | 1,120 |
| Capital Expenditure | N/A | -97 | N/A | N/A | N/A |
| Free Cash Flow | -5,052 | 2,464 | -9,507 | -2,430 | 1,120 |